ViVitro Labs at TCT 2017 will highlight the ViVitro Endovascular Simulator and Pulse Duplicator for cardiovascular devices in booth 4036. Taking place October 29 – November 2, 2017 in Denver Colorado, Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine.
The ViVitro Endovascular Simulator provides physiological pulsatile flow and pressures mimicking endovascular procedures in a clinically relevant environment. It is designed for simulated-use testing and endovascular simulation training of endovascular devices. ISO 5840, ISO 25539, and ISO 7198 standards include simulated use guidelines. The Endovascular Simulator provides functional design testing for:
- stent grafts
- transcatheter heart valves
The Pulse Duplicator simulates the function of the heart (left or right) by generating pulsatile flow through prosthetic heart valves placed in the Model Left Heart. Powered by the ViVitro SuperPump, it is composed of the Model Left Heart, SuperPump, Flow Measuring System and ViViTest data acquisition system. The components work together to assess the performance of prosthetic heart valves under simulated cardiac conditions. The Pulse Duplicator System is used by the US Food and Drug Administration and is recognised by regulatory bodies worldwide including TÜV, BSI and the Chinese SFDA.
Representing ViVitro Labs at TCT 2017 will be team members Major Accounts Manager. Douglas Bigrigg, and Laboratory Manager, Rob Fraser. Charles Garcia, VP of Business Development Eastern Region at ViVitro’s sister company and equipment manufacturer, StarFish Medical, will join Doug and Rob in the company booth. All of the team members are happy to set up private meetings at the show and can be contacted at firstname.lastname@example.org to arrange an appointment.
About ViVitro Labs
ViVitro Labs Inc. offers industry-leading cardiovascular test equipment and related laboratory testing and consulting services. Hundreds of organizations in over 40 countries for 30 years have trusted ViVitro expertise, accuracy, and quality for their heart valve, LVAD, TAH, stent, and graft testing. ViVitro Laboratory Services holds ISO/IEC 17025 accreditation based on ISO 5840. ViVitro products are manufactured by StarFish Medical. ViVitro’s A2LA Scope of Accreditation includes the physical and mechanical testing of heart valve substitutes.
For more information please contact:
# # #